Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs. read more
Robert Allen — Vice President Antiviral and Oncolytic Immunotherapy Development at Sorrento Therapeutics
Executive Bio
Robert Allen serves as the Vice President Antiviral and Oncolytic Immunotherapy Development of Sorrento Therapeutics. Robert Allen and the Sorrento Therapeutics executive team are rated a C by 8 employees.
Executive Team Culture Ratings from Sorrento Therapeutics Employees
BOTTOM
45%
Sorrento Therapeutics' Executive Team scores in the Bottom 45%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Sorrento TherapeuticsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Sorrento TherapeuticsSorrento Therapeutics' Executive Team at a Glance
Based on 9 ratings, Sorrento Therapeutics' employees are less satisfied with their Executive Team and give them a “C” or 69/100.
Sorrento Therapeutics' Executive Team ranks in the Top 50% of other companies in San Diego and Bottom 45% of other companies on Comparably that also have 51-200 Employees.
×